Gastroenterologist Naresh Gunaratnam, MD warns that insurers are undermining colorectal cancer care by mailing unsolicited Cologuard kits directly to patients — often those for whom stool testing is inappropriate. One patient with a prior colectomy endured needless anxiety and procedures after a false positive.
Gunaratnam argues this practice confuses patients, bypasses physicians, and contradicts national GI society guidelines.